Patients with inflammatory bowel disease (IBD) or primary sclerosing cholangitis (PSC) show promising outcomes when receiving advanced therapies following liver transplantation, according to study ...

A remarkable development in breast cancer research has revealed a fundamental mechanism behind driving cancer invasion and ...

免疫性炎症是由于免疫系统异常反应并攻击正常组织而引起的炎症。这种炎症反应并非由外部病原体（如细菌、病毒等）直接引起，而是由于免疫系统的错误激活导致了自身组织的损伤。常见的免疫性炎症反应包括自身免疫性肝炎、系统性红斑狼疮、类风湿关节炎、溃疡性结肠炎等。

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ORLANDO -- Vedolizumab (Entyvio) and infliximab ...

Scientists discovered how cancer cells migrate by digesting the surrounding tissue matrix, enabling them to spread. A ...

Cancer is one of the most formidable health challenges of our time, affecting nearly half of us during our lives. While treatments have significantly improved in recent decades, the biggest challenge ...

Bexotegrast is a small molecule commercialized by Pliant Therapeutics, with a leading Phase III program in Idiopathic Pulmonary Fibrosis.

By far, the largest acquisition of 2024 was Novo Holdings' yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion.

The company will develop a pipeline of small molecule inhibitors that target a unique lipid-binding pocket on proteins.

Corbus Pharmaceuticals (CRBP) announced the dosing of the first patient in the Phase 1 portion of the clinical study of CRB-601 for the ...

CRB-601 is an anti-αvβ8 monoclonal antibody designed to block activation of latent TGFβ in the tumor micro-environmentNORWOOD ...

A significant breakthrough in breast cancer research has uncovered a key mechanism driving cancer invasion and drug ...